Clinical trial
Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIV
NCT00122512 · FHI 360, Other · Terminated
Key facts
| NCT number | NCT00122512 |
|---|---|
| Title | Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIV |
| Official title | Phase 2a Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIV - An Extended Safety Evaluation |
| Lead sponsor | FHI 360, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Tenofovir Disoproxil Fumarate |
| Enrollment | 500 |
| First posted | Jul 22, 2005 |
| Last update posted | Feb 10, 2006 |
| Countries | Malawi |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: